发明公开
EP2286834A3 Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response
审中-公开
使用药物来改善皮肤渗透和突破障碍剂，以提高经皮免疫反应
- 专利标题： Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response
- 专利标题（中）： 使用药物来改善皮肤渗透和突破障碍剂，以提高经皮免疫反应
-
申请号： EP10012335.5申请日： 1999-02-25
-
公开(公告)号： EP2286834A3公开(公告)日： 2012-01-25
- 发明人: Glenn, Gregory, Dr. , Alving, Carl
- 申请人： THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY
- 申请人地址： c/o Medical Research & Materiel Command, 504 Scott Street Fort Detrick, MD 21702 US
- 专利权人： THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY
- 当前专利权人： THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY
- 当前专利权人地址： c/o Medical Research & Materiel Command, 504 Scott Street Fort Detrick, MD 21702 US
- 代理机构： Vossius & Partner
- 优先权： US75850P 19980225; US75856P 19980225
- 主分类号： A61K39/39
- IPC分类号： A61K39/39 ; A61K9/00 ; C12N15/11 ; A61K39/00 ; A61K38/16 ; A61K39/02 ; A61K39/106
摘要：
Disclosed is a formulation comprising an antigen and an adjuvant for transcutancous immunization of a subject, wherein the antigen induces an immune response specific for the antigen following application of the formulation to the subject's unperforated skin which is treated to disrupt the stratum corneum.
公开/授权文献
信息查询
